XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Awards (Tables)
9 Months Ended
Sep. 30, 2022
Stock-Based Awards  
Assumptions used to determine fair value of stock options granted

    

Nine Months Ended

September 30, 

2022

2021

Risk-free interest rate

 

2.07

%

0.90

%

Expected term (in years)

 

6.2

6.2

Expected volatility

 

77.95

%

76.60

%

Expected dividend yield

 

0

%

0

%

Summary of stock option activity

    

    

    

Weighted

    

Weighted

Average

Average

Remaining

Aggregate

Number

Exercise

Contractual

Intrinsic

(In thousands, except share and per share data and years)

of Shares

Price

Term

Value

(in years)

Outstanding as of December 31, 2021

 

3,792,450

$

17.50

 

6.8

$

13,710

Granted

 

2,334,750

14.27

Exercised

 

(85,672)

1.40

1,115

Forfeited and cancelled

 

(853,864)

18.70

Outstanding as of September 30, 2022

 

5,187,664

$

16.11

 

7.4

$

15,376

Options vested and expected to vest as of September 30, 2022

 

5,187,664

$

16.11

 

7.4

$

15,376

Options exercisable as of September 30, 2022

 

2,307,984

$

17.35

 

5.2

$

9,345

Summary of restricted stock units activity

Weighted

Average

Grant Date

Aggregate

Number

Fair Value

Intrinsic

(In thousands, except share and per share data)

of Shares

Per Share

Value

Outstanding as of December 31, 2021

1,496,946

$

12.75

Granted

867,707

14.33

Vested

(526,706)

11.55

$

7,839

Forfeited and cancelled

(252,763)

12.30

Outstanding as of September 30, 2022

1,585,184

$

14.09

Stock-based compensation expense

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(In thousands)

    

2022

    

2021

    

2022

    

2021

Cost of revenue

    

$

307

    

$

206

  

$

837

    

$

787

Research and development

1,400

939

2,228

2,969

General and administrative

 

2,481

 

2,557

 

7,161

 

6,453

Total stock-based compensation expense

$

4,188

$

3,702

$

10,226

$

10,209